Weiss Multi-Strategy Advisers LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$328,000
-50.6%
20,000
-60.0%
0.01%
-61.5%
Q3 2019$664,000
-41.1%
50,000
-37.5%
0.01%
-56.7%
Q2 2019$1,127,000
-27.9%
80,000
-5.9%
0.03%
-23.1%
Q1 2019$1,564,000
-32.0%
85,000
-3.4%
0.04%
-59.4%
Q4 2018$2,300,000
+150.5%
88,000
+120.0%
0.10%
+300.0%
Q3 2018$918,000
+22.4%
40,000
+1.6%
0.02%
+33.3%
Q2 2018$750,000
+11.3%
39,358
-1.6%
0.02%
-14.3%
Q1 2018$674,000
-11.3%
40,000
-20.0%
0.02%
+5.0%
Q4 2017$760,000
-22.8%
50,000
-9.1%
0.02%
-45.9%
Q3 2017$985,000
+4.2%
55,000
-5.2%
0.04%
-7.5%
Q2 2017$945,000
+12.5%
58,000
-3.3%
0.04%
+21.2%
Q1 2017$840,000
+5.3%
60,000
+20.0%
0.03%
-15.4%
Q4 2016$798,000
+299.0%
50,000
+316.7%
0.04%
+225.0%
Q3 2016$200,000
+138.1%
12,000
+20.0%
0.01%
+200.0%
Q1 2016$84,000
-27.6%
10,000
-20.0%
0.00%
-50.0%
Q4 2015$116,000
-17.7%
12,5000.0%0.01%
+33.3%
Q3 2015$141,000
-68.2%
12,500
-64.3%
0.01%
-66.7%
Q2 2015$444,000
+2.8%
35,000
-24.6%
0.02%
-5.3%
Q1 2015$432,000
-39.7%
46,400
-7.2%
0.02%
-24.0%
Q4 2014$716,000
+6.1%
50,000
-23.1%
0.02%
+56.2%
Q3 2014$675,000
-44.4%
65,000
-13.3%
0.02%
-38.5%
Q2 2014$1,214,000
+54.5%
75,000
+55.1%
0.03%
+62.5%
Q1 2014$786,000
+5.5%
48,360
-19.4%
0.02%0.0%
Q4 2013$745,000
-15.0%
60,000
-25.0%
0.02%
+77.8%
Q3 2013$876,000
+8.4%
80,000
-20.0%
0.01%
-62.5%
Q2 2013$808,000100,0000.02%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders